These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer. Dreicer R; Forest PK; Williams RD Urology; 1994 Sep; 44(3):377-80. PubMed ID: 7521094 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma. Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632 [TBL] [Abstract][Full Text] [Related]
5. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of repeated single 24-hour infusion of low-dose 5-fluorouracil for palliation in symptomatic hormone-refractory prostate cancer. Bex A; Otto T; Lümmen G; Rübben H Urol Int; 2002; 69(4):273-7. PubMed ID: 12444282 [TBL] [Abstract][Full Text] [Related]
7. Treatment of stage D2 hormone refractory carcinoma of the prostate with 5-fluorouracil and Roferon-A: a Southwest Oncology Group study. Marshall ME; Wolf M; O'Rourke M; Barnett TC; Crawford ED Cancer Biother Radiopharm; 1996 Apr; 11(2):119-23. PubMed ID: 10851528 [TBL] [Abstract][Full Text] [Related]
8. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules. John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541 [TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma. Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795 [TBL] [Abstract][Full Text] [Related]
10. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485 [TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma. Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037 [TBL] [Abstract][Full Text] [Related]
12. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma. Wadler S; Goldman M; Lyver A; Wiernik PH Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795 [TBL] [Abstract][Full Text] [Related]
13. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a. Yee LK; Allegra CJ; Steinberg SM; Grem JL J Natl Cancer Inst; 1992 Dec; 84(23):1820-5. PubMed ID: 1433371 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336 [TBL] [Abstract][Full Text] [Related]
15. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study. Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927 [TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial. Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292. Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668 [TBL] [Abstract][Full Text] [Related]
18. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer. Piga A; Cascinu S; Latini L; Marcellini M; Bavosi M; Acito L; Bascioni R; Giustini L; Francini G; Pancotti A; Rossi G; Del Papa M; Carle F; Cellerino R Br J Cancer; 1996 Sep; 74(6):971-4. PubMed ID: 8826868 [TBL] [Abstract][Full Text] [Related]
19. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group. J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120 [TBL] [Abstract][Full Text] [Related]
20. A report of infusional 5-fluorouracil and subcutaneous alpha-2A-interferon in the treatment of advanced colorectal carcinoma. Koo WH; Ang PT Ann Acad Med Singap; 1996 Mar; 25(2):210-4. PubMed ID: 8799007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]